Am grateful to Katie Deighton of The Wall Street Journal for her interview about the challenges we faced commercialising a completely new & innovative period care product, and our pivot to the medical devices (drug delivery) space. Understandably there hasn’t been anywhere near the press interest we had when things looked incredibly promising, to focus …

It was an exciting start to London Tech Week 2023 by taking part in FemTech Lab’s Decoding The Future of Women Summit.  Always a privilege to be able to share Calla Lily Clinical Care’s exciting progress with our technology and to discuss trends & observations about the future of femtech with such an esteemed panel.